Acorah Software Products - Accounts Production16.7.461falsetrue31 March 20241 April 2023falsetrueNo description of principal activity1 April 202431 March 202531 March 202507596858Ms Agata Glogowskaiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure075968582024-03-31075968582025-03-31075968582024-04-012025-03-3107596858frs-core:CurrentFinancialInstruments2025-03-3107596858frs-bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107596858frs-bus:FilletedAccounts2024-04-012025-03-3107596858frs-bus:Micro-entities2024-04-012025-03-3107596858frs-bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107596858frs-bus:Director12024-04-012025-03-31075968582023-03-31075968582024-03-31075968582023-04-012024-03-3107596858frs-core:CurrentFinancialInstruments2024-03-31
Registered number: 07596858
Ag Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 March 2025
Ag Pharma Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 07596858
2025
2024
£
£
Current assets
99,093
81,473
Creditors: Amounts Falling Due Within One Year
(10,063)
(10,291)
NET CURRENT ASSETS
89,030
71,182
TOTAL ASSETS LESS CURRENT LIABILITIES
89,030
71,182
NET ASSETS
89,030
71,182
CAPITAL AND RESERVES
89,030
71,182
Notes
1.General Information
Ag Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07596858. The registered office is Apartment E409, 35 Indescon Square, London, E14 9DR.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
11
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.